World Wires · story 58605 · unverified · 1 source(s)

Novo Nordisk and Eli Lilly report GLP-1 signs of slowed biological aging

Novo Nordisk and Eli Lilly presented findings at ARDD indicating potential signals of slowed biological aging associated with GLP-1 treatments.

Open in the desk

Coverage

What this site indexes